Dynamical effects of epigenetic silencing of 14-3-3sigma expression.
暂无分享,去创建一个
Olaf Wolkenhauer | Julio Vera | Manfred Kunz | Julia Schultz | Saleh Ibrahim | O. Wolkenhauer | J. Vera | M. Kunz | Yvonne Raatz | Y. Raatz | J. Schultz | S. Ibrahim | Yvonne Raatz
[1] H. Spaink,et al. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3σ and 14-3-3ζ , 2004, Journal of Cell Science.
[2] Sebastian Bohl,et al. Computational processing and error reduction strategies for standardized quantitative data in biological networks , 2005, The FEBS journal.
[3] Eva Balsa-Canto,et al. Power-law models of signal transduction pathways. , 2007, Cellular signalling.
[4] B. Gusterson,et al. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. , 2002, Cancer research.
[5] Satoshi Inoue,et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.
[6] Tomasz Lipniacki,et al. Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.
[7] Mong-Hong Lee,et al. 14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth , 2003, Molecular and Cellular Biology.
[8] R. Marais,et al. Melanoma biology and new targeted therapy , 2007, Nature.
[9] L. Elmore,et al. Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.
[10] R. Spang,et al. Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues , 2007, Clinical Cancer Research.
[11] U Alon,et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[13] H. Hermeking,et al. 14-3-3 proteins in cell cycle regulation. , 2006, Seminars in cancer biology.
[14] Mark E. Davis,et al. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging , 2006, Nucleic acids research.
[15] K. Kinzler,et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.
[16] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[17] H. Hermeking,et al. Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression , 2004, Oncogene.
[18] H. Hermeking. The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.
[19] R. Milo,et al. Oscillations and variability in the p53 system , 2006, Molecular systems biology.
[20] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[21] Olaf Wolkenhauer,et al. Dynamic properties of a delayed protein cross talk model , 2008, Biosyst..
[22] Mats Jirstrand,et al. Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .
[23] H. Hermeking,et al. Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation , 2005, Modern Pathology.
[24] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[25] Uri Alon,et al. Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.
[26] Yuquan Wei,et al. Gene expression and methylation status of 14‐3‐3σ in human renal carcinoma tissues , 2008, IUBMB life.
[27] John Jeremy Rice,et al. A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Vera,et al. 14-3-3σ gene silencing during melanoma progression and its role in cell cycle control and cellular senescence , 2009, Molecular Cancer.
[29] Hiromu Suzuki,et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2000, Oncogene.
[30] M.-H. Lee,et al. Roles for negative cell regulator 14-3-3σ in control of MDM2 activities , 2007, Oncogene.
[31] T. Pandita,et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] Michael D. Abràmoff,et al. Image processing with ImageJ , 2004 .
[33] L. Chin. The genetics of malignant melanoma: lessons from mouse and man , 2003, Nature Reviews Cancer.
[34] K. Kinzler,et al. 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .
[35] M. Sugiyama,et al. Methylation and intratumoural heterogeneity of 14-3-3 σ in oral cancer , 2007 .
[36] Satoshi Nishizuka,et al. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. , 2007, Cancer research.
[37] S. Schwarze,et al. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. , 2005, Neoplasia.
[38] John R Yates,et al. Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer*S , 2005, Molecular & Cellular Proteomics.